Concepts (232)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiopulmonary Resuscitation | 13 | 2024 | 247 | 2.180 |
Why?
|
| Heart Arrest | 12 | 2019 | 311 | 1.380 |
Why?
|
| Hypothermia, Induced | 7 | 2019 | 90 | 0.990 |
Why?
|
| Respiratory Rate | 1 | 2022 | 25 | 0.730 |
Why?
|
| Chest Pain | 1 | 2022 | 45 | 0.730 |
Why?
|
| Diagnosis, Computer-Assisted | 3 | 2019 | 337 | 0.630 |
Why?
|
| Electrocardiography | 1 | 2022 | 493 | 0.620 |
Why?
|
| Emergency Service, Hospital | 7 | 2022 | 579 | 0.590 |
Why?
|
| Heart-Assist Devices | 5 | 2024 | 882 | 0.570 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 2 | 2019 | 103 | 0.520 |
Why?
|
| Depressive Disorder | 1 | 2016 | 225 | 0.440 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2019 | 366 | 0.430 |
Why?
|
| Hyperthermia, Induced | 1 | 2014 | 75 | 0.420 |
Why?
|
| Quality of Life | 6 | 2024 | 1780 | 0.410 |
Why?
|
| Depression | 3 | 2022 | 544 | 0.410 |
Why?
|
| Depressive Disorder, Major | 3 | 2022 | 171 | 0.410 |
Why?
|
| Shock, Hemorrhagic | 2 | 2011 | 12 | 0.410 |
Why?
|
| Heart Failure | 4 | 2024 | 1386 | 0.400 |
Why?
|
| Referral and Consultation | 3 | 2021 | 375 | 0.380 |
Why?
|
| Patient Care Team | 1 | 2014 | 298 | 0.360 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2010 | 83 | 0.320 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2010 | 9 | 0.320 |
Why?
|
| Myocardium | 2 | 2010 | 570 | 0.320 |
Why?
|
| Cardiac Output | 1 | 2010 | 141 | 0.310 |
Why?
|
| Patient Reported Outcome Measures | 4 | 2024 | 283 | 0.300 |
Why?
|
| Gene Deletion | 1 | 2010 | 352 | 0.300 |
Why?
|
| Health Personnel | 2 | 2021 | 234 | 0.290 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2010 | 258 | 0.280 |
Why?
|
| Middle Aged | 22 | 2024 | 27573 | 0.270 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 1053 | 0.270 |
Why?
|
| Basal Ganglia | 2 | 1998 | 46 | 0.260 |
Why?
|
| Mice, Inbred C57BL | 10 | 2019 | 3435 | 0.250 |
Why?
|
| Community Health Centers | 2 | 2019 | 119 | 0.250 |
Why?
|
| Humans | 30 | 2024 | 93515 | 0.240 |
Why?
|
| Health Promotion | 2 | 2019 | 170 | 0.240 |
Why?
|
| Female | 28 | 2024 | 48702 | 0.240 |
Why?
|
| Blood Glucose | 1 | 2009 | 867 | 0.220 |
Why?
|
| DNA | 1 | 2010 | 1265 | 0.220 |
Why?
|
| Self Report | 1 | 2024 | 328 | 0.190 |
Why?
|
| Aged | 15 | 2024 | 20434 | 0.190 |
Why?
|
| Male | 21 | 2024 | 44557 | 0.190 |
Why?
|
| Adult | 16 | 2024 | 27918 | 0.180 |
Why?
|
| Health Information Exchange | 1 | 2021 | 12 | 0.180 |
Why?
|
| Systems Analysis | 1 | 2021 | 16 | 0.180 |
Why?
|
| Mental Health | 1 | 2023 | 188 | 0.170 |
Why?
|
| Hospitalization | 3 | 2021 | 937 | 0.170 |
Why?
|
| Community Networks | 1 | 2021 | 32 | 0.170 |
Why?
|
| Heart Rate | 1 | 2024 | 505 | 0.170 |
Why?
|
| Occupational Diseases | 1 | 2021 | 53 | 0.160 |
Why?
|
| Respiration | 1 | 2022 | 269 | 0.160 |
Why?
|
| Population Health | 2 | 2019 | 33 | 0.160 |
Why?
|
| Hemodynamics | 4 | 2015 | 713 | 0.160 |
Why?
|
| Reproducibility of Results | 4 | 2023 | 2715 | 0.160 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2019 | 502 | 0.150 |
Why?
|
| Pandemics | 2 | 2022 | 873 | 0.150 |
Why?
|
| Machine Learning | 1 | 2022 | 341 | 0.140 |
Why?
|
| Mice | 9 | 2015 | 12269 | 0.140 |
Why?
|
| Electronic Health Records | 2 | 2019 | 372 | 0.140 |
Why?
|
| Diagnosis, Differential | 1 | 2022 | 1546 | 0.140 |
Why?
|
| Hospital Costs | 1 | 2019 | 116 | 0.140 |
Why?
|
| Sensation | 1 | 1998 | 48 | 0.140 |
Why?
|
| Young Adult | 6 | 2021 | 6930 | 0.140 |
Why?
|
| Adolescent | 6 | 2021 | 9606 | 0.130 |
Why?
|
| Animals | 15 | 2019 | 28155 | 0.130 |
Why?
|
| Blood Circulation | 1 | 2017 | 29 | 0.130 |
Why?
|
| Heart Massage | 1 | 2017 | 11 | 0.130 |
Why?
|
| Emergency Medical Services | 1 | 2010 | 269 | 0.130 |
Why?
|
| Disease Progression | 1 | 2021 | 1531 | 0.130 |
Why?
|
| Electronic Prescribing | 1 | 2016 | 10 | 0.130 |
Why?
|
| Smoking Cessation | 1 | 2019 | 269 | 0.120 |
Why?
|
| Reperfusion Injury | 2 | 2007 | 148 | 0.120 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2019 | 217 | 0.120 |
Why?
|
| Random Allocation | 5 | 2019 | 307 | 0.120 |
Why?
|
| Retrospective Studies | 6 | 2021 | 10164 | 0.110 |
Why?
|
| Primary Health Care | 1 | 2019 | 378 | 0.110 |
Why?
|
| Quinazolinones | 1 | 2015 | 15 | 0.110 |
Why?
|
| Dynamins | 1 | 2015 | 48 | 0.110 |
Why?
|
| Mitochondrial Dynamics | 1 | 2015 | 59 | 0.110 |
Why?
|
| Disease Models, Animal | 5 | 2015 | 2495 | 0.100 |
Why?
|
| Registries | 3 | 2021 | 990 | 0.100 |
Why?
|
| Cerebral Cortex | 1 | 1998 | 578 | 0.100 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2015 | 147 | 0.100 |
Why?
|
| Survival Rate | 4 | 2013 | 1948 | 0.100 |
Why?
|
| Organometallic Compounds | 1 | 2015 | 139 | 0.100 |
Why?
|
| Enzyme Inhibitors | 2 | 2015 | 641 | 0.100 |
Why?
|
| Aldehyde-Lyases | 1 | 2013 | 15 | 0.100 |
Why?
|
| Case-Control Studies | 3 | 2023 | 1931 | 0.100 |
Why?
|
| Surveys and Questionnaires | 4 | 2024 | 2802 | 0.100 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2013 | 79 | 0.100 |
Why?
|
| Sphingosine | 1 | 2013 | 73 | 0.100 |
Why?
|
| Lysophospholipids | 1 | 2013 | 67 | 0.100 |
Why?
|
| Energy Metabolism | 1 | 2015 | 299 | 0.090 |
Why?
|
| Cardiac Catheterization | 2 | 2017 | 295 | 0.090 |
Why?
|
| Decision Making | 1 | 2016 | 674 | 0.090 |
Why?
|
| Phosphorylation | 2 | 2011 | 1133 | 0.080 |
Why?
|
| Myoglobin | 1 | 2010 | 29 | 0.080 |
Why?
|
| Time Factors | 3 | 2023 | 5410 | 0.080 |
Why?
|
| Chemokines | 1 | 2010 | 76 | 0.080 |
Why?
|
| Sodium Nitrite | 1 | 2009 | 2 | 0.080 |
Why?
|
| Ice | 2 | 2006 | 11 | 0.080 |
Why?
|
| Reactive Oxygen Species | 2 | 2009 | 502 | 0.080 |
Why?
|
| Electron Transport Complex I | 1 | 2009 | 34 | 0.080 |
Why?
|
| Ileum | 1 | 2010 | 167 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 367 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2010 | 784 | 0.070 |
Why?
|
| Decision Trees | 2 | 2021 | 64 | 0.070 |
Why?
|
| Models, Animal | 1 | 2010 | 282 | 0.070 |
Why?
|
| Nervous System | 1 | 2009 | 92 | 0.070 |
Why?
|
| Interleukin-6 | 1 | 2010 | 276 | 0.070 |
Why?
|
| Hypoglycemia | 1 | 2009 | 113 | 0.070 |
Why?
|
| Body Temperature | 2 | 2007 | 131 | 0.070 |
Why?
|
| Hyperglycemia | 1 | 2009 | 181 | 0.070 |
Why?
|
| United States | 4 | 2021 | 7622 | 0.070 |
Why?
|
| Stroke Volume | 1 | 2010 | 438 | 0.070 |
Why?
|
| Anxiety | 2 | 2022 | 337 | 0.070 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 7061 | 0.060 |
Why?
|
| Oxidants | 1 | 2007 | 86 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 688 | 0.060 |
Why?
|
| Heart | 1 | 2009 | 522 | 0.060 |
Why?
|
| Carbon Dioxide | 1 | 2007 | 203 | 0.060 |
Why?
|
| Single-Blind Method | 2 | 2021 | 159 | 0.060 |
Why?
|
| Risk Factors | 2 | 2021 | 5899 | 0.060 |
Why?
|
| Mass Screening | 2 | 2021 | 696 | 0.050 |
Why?
|
| Myocytes, Cardiac | 1 | 2007 | 313 | 0.050 |
Why?
|
| Sodium Chloride | 1 | 2004 | 84 | 0.050 |
Why?
|
| Vaccines, Combined | 1 | 2023 | 6 | 0.050 |
Why?
|
| Catheterization, Central Venous | 1 | 2004 | 111 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2022 | 917 | 0.050 |
Why?
|
| Self Care | 1 | 2024 | 167 | 0.050 |
Why?
|
| Mitochondria | 1 | 2007 | 612 | 0.050 |
Why?
|
| Chicago | 2 | 2019 | 1464 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2023 | 9099 | 0.050 |
Why?
|
| Information Systems | 1 | 2023 | 29 | 0.050 |
Why?
|
| Immunoblotting | 2 | 2015 | 273 | 0.050 |
Why?
|
| Analysis of Variance | 3 | 2011 | 884 | 0.050 |
Why?
|
| Resuscitation | 2 | 2015 | 130 | 0.050 |
Why?
|
| Adaptation, Psychological | 1 | 2023 | 170 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2009 | 767 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2022 | 4560 | 0.040 |
Why?
|
| Patient Care | 1 | 2023 | 97 | 0.040 |
Why?
|
| Immunization, Secondary | 1 | 2021 | 37 | 0.040 |
Why?
|
| Kidney | 1 | 2006 | 1111 | 0.040 |
Why?
|
| Immunization, Passive | 1 | 2021 | 68 | 0.040 |
Why?
|
| Immunization Schedule | 1 | 2021 | 23 | 0.040 |
Why?
|
| Cannula | 1 | 2021 | 54 | 0.040 |
Why?
|
| Patient Satisfaction | 1 | 2024 | 484 | 0.040 |
Why?
|
| Anxiety Disorders | 1 | 2022 | 155 | 0.040 |
Why?
|
| Health Status | 1 | 2023 | 377 | 0.040 |
Why?
|
| Cough | 1 | 2021 | 56 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2021 | 292 | 0.040 |
Why?
|
| Infusions, Intravenous | 1 | 2021 | 401 | 0.040 |
Why?
|
| Antibodies, Neutralizing | 1 | 2021 | 162 | 0.040 |
Why?
|
| Electric Impedance | 1 | 2010 | 115 | 0.040 |
Why?
|
| Fever | 1 | 2021 | 122 | 0.040 |
Why?
|
| Swine | 3 | 2006 | 588 | 0.040 |
Why?
|
| Laparoscopy | 1 | 2006 | 782 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 322 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2021 | 894 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 452 | 0.040 |
Why?
|
| Muscle Contraction | 1 | 2019 | 256 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 1847 | 0.040 |
Why?
|
| Globus Pallidus | 1 | 1998 | 18 | 0.030 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2019 | 156 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2023 | 2026 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2023 | 2479 | 0.030 |
Why?
|
| Electrophysiology | 1 | 1998 | 390 | 0.030 |
Why?
|
| Poverty | 1 | 2019 | 193 | 0.030 |
Why?
|
| Electric Stimulation | 1 | 1998 | 344 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2021 | 1118 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 1998 | 405 | 0.030 |
Why?
|
| Suicidal Ideation | 1 | 2017 | 75 | 0.030 |
Why?
|
| Thalamus | 1 | 1998 | 132 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2021 | 1006 | 0.030 |
Why?
|
| Medical Informatics | 1 | 2016 | 48 | 0.030 |
Why?
|
| Glucose | 1 | 2019 | 692 | 0.030 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2017 | 75 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 492 | 0.030 |
Why?
|
| Psychometrics | 1 | 2017 | 337 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2023 | 3830 | 0.030 |
Why?
|
| Coronavirus Infections | 1 | 2021 | 333 | 0.030 |
Why?
|
| Synapses | 1 | 1998 | 274 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 1587 | 0.030 |
Why?
|
| Suicide | 1 | 2017 | 162 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2019 | 896 | 0.030 |
Why?
|
| Aconitate Hydratase | 1 | 2015 | 11 | 0.030 |
Why?
|
| Length of Stay | 1 | 2019 | 828 | 0.030 |
Why?
|
| Models, Neurological | 1 | 1998 | 408 | 0.030 |
Why?
|
| Prevalence | 1 | 2019 | 1321 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2015 | 137 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2021 | 3054 | 0.030 |
Why?
|
| Nerve Net | 1 | 1998 | 394 | 0.030 |
Why?
|
| Visual Cortex | 1 | 1997 | 246 | 0.030 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2013 | 25 | 0.030 |
Why?
|
| Ceramides | 1 | 2013 | 36 | 0.020 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2013 | 38 | 0.020 |
Why?
|
| Inflammation | 1 | 2019 | 1050 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 1917 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2013 | 104 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2013 | 108 | 0.020 |
Why?
|
| Imidazoles | 1 | 2013 | 138 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2011 | 27 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2011 | 122 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2011 | 136 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 251 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2011 | 122 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 302 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 2011 | 125 | 0.020 |
Why?
|
| Cytokines | 1 | 2015 | 863 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2011 | 178 | 0.020 |
Why?
|
| Algorithms | 1 | 1998 | 1953 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2009 | 212 | 0.020 |
Why?
|
| Ventricular Fibrillation | 1 | 2008 | 67 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2011 | 537 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2013 | 2121 | 0.020 |
Why?
|
| Polyenes | 1 | 2007 | 8 | 0.020 |
Why?
|
| Hypocapnia | 1 | 2007 | 7 | 0.020 |
Why?
|
| Partial Pressure | 1 | 2007 | 49 | 0.020 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2007 | 45 | 0.020 |
Why?
|
| Hypercapnia | 1 | 2007 | 49 | 0.020 |
Why?
|
| Chick Embryo | 1 | 2007 | 222 | 0.020 |
Why?
|
| Emergency Medical Technicians | 1 | 2006 | 14 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 2007 | 262 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2007 | 493 | 0.020 |
Why?
|
| Manikins | 1 | 2006 | 45 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2007 | 281 | 0.010 |
Why?
|
| Apoptosis | 1 | 2011 | 1721 | 0.010 |
Why?
|
| Fatigue | 1 | 2006 | 181 | 0.010 |
Why?
|
| Cell Survival | 1 | 2007 | 1004 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 1985 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2006 | 756 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2013 | 3502 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2007 | 2850 | 0.010 |
Why?
|